A novel nicotinic-cholinergic role in behavioral sensitization to amphetamine-induced stereotypy in mice

Brain Research

Volumn 725, Issue 2, 1996, Pages 192-198

  Karler, Ralph ^a   Calder, Larry D ^a   Bedingfield, J Brent ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Behavioral sensitization; Cholinergic; Cocaine; Mice; Nicotinic; Stereotypy

Indexed keywords

ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; COCAINE; DEXAMPHETAMINE; DIHYDRO BETA ERYTHROIDINE; MECAMYLAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT; PSYCHOSTIMULANT AGENT; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030182401     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00248-X     Document Type: Article

References (37)

1. [1] Amalric, M. and Koob, G.F., Functionally selective neurochemical afferents and efferents of the mesolimbic and nigrostriatal dopamine system, Prog. Brain Res., 99 (1993) 209-229.
2. [2] Araujo, D.M., Lapchak, P.A., Collier, B. and Quirion, R., Characterization of N-[ + 3H] methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain, J. Neurochem., 51 (1988) 292-299.
3. [3] Barbeau, A., The pathogenesis of Parkinson's disease: a new hypothesis, Can. Med. Assoc., 87 (1962) 802-807.
4. [4] Bedingfield, J.B., Calder, L.D. and Karler, R., Comparative behavioral sensitization to stereotypy by direct and indirect dopamine agonists in CF-1 mice, Psychopharmacology, (1996) in press.
5. [5] Chance, M.R.A., Aggregation as a factor influencing the toxicity of sympathomimetic amines in mice, J. Pharmacol. Exp. Ther., 87 (1946) 214-219.
6. [6] Chang, H.T., Dopamine-acetylcholine interaction in the rat striatum: a dual-labeling immunocytochemical study, Brain Res. Bull., 21 (1988) 295-304.
7. [7] Chaudhry, I.A., Turkanis, S.A. and Karler, R., Characteristics of 'reverse tolerance' to amphetamine-induced locomotor stimulation in mice, Neuropharmacology, 27 (1988) 777-781.
8. [8] Clarke, P.B.S., Nicotinic receptors in mammalian brain: localization and relation to cholinergic innervation, Prog. Brain Res., 98 (1993) 77-83.
9. 1 receptors localized in the striatum, J. Neurochem., 59 (1992) 1555-1557.
10. 1 and N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther., 259 (1991) 1064-1072.
11. [11] Day, J. and Fibiger, H.C., Dopaminergic regulation of cortical acetylcholine release: effects of dopamine receptor agonists, Neuroscience, 54 (1993) 643-648.
12. [12] DeBoer, P., Damsma, G., Schram, Q., Stoof, J.C., Zaagsma, J. and Westerink, B.H.C., The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis, Naunyn-Schmiedeberg's Arch. Pharmacol., 345 (1992) 144-152.
13. [13] Ellinwood, E.H. and Balster, R.L., Rating the behavioral effects of amphetamine, Eur. J. Pharmacol., 28 (1974) 35-41.
14. [14] Florin, S.M., Kuczenski, R. and Segal, D.S., Amphetamine-induced changes in behavior and caudate extracellular acetylcholine. Brain Res., 381 (1992) 53-58.
15. [15] Graybiel, A.M., Neurotransmitters and neuromodulators in the basal ganglia, Trends Neurosci., 13 (1990) 244-254.
16. [16] Graybiel, A.M., Moratalla, R. and Robertson, H.A., Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments of limbic subdivisions of the striatum, Proc. Natl. Acad. Sci. USA, 87 (1990) 6912-6916.
17. [17] Guix, T., Hurd, Y.L. and Ungerstedt, U., Amphetamine enhances extracellular concentrations of dopamine and acetylcholine in dorso-lateral striatum and nucleus accumbens of freely moving rats, Neurosci. Lett., 138 (1992) 137-140.
18. [18] Kalivas, P.W. and Weber, B., Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine, J. Pharmacol Exp. Ther., 245 (1988) 1095-1102.
19. [19] Karler, R., Chaudhry, I.A., Calder, L.D. and Turkanis, S.A., Amphetamine behavioral sensitization and the excitatory amino acids, Brain Res., 537 (1990) 76-82.
20. [20] Karler, R., Calder, L.D. and Turkanis, S.A., DNQX blockade of amphetamine behavioral sensitization, Brain Res., 552 (1991) 295-300.
21. [21] Karler, R., Turkanis, S.A., Partlow, L.M. and Calder, L.D., Calcium channel blockers and behavioral sensitization, Life Sci., 49 (1991) 165-170.
22. [22] Karler, R., Finnegan, K.T. and Calder, L.D., Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis, Brain Res., 603 (1993) 19-24.
23. [23] Karler, R., Calder, L.D., Thai, L.H. and Bedingfield, J.B., A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine, Brain Res., 658 (1994) 8-14.
24. [24] Karler, R., Calder, L.D., Thai, L.H. and Bedingfield, J.B., The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine, Brain Res., 671 (1995) 100-104.
25. [26] Kita, H. and Kitai, S.T., Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations, Brain Res., 447 (1988) 346-352.
26. [27] Kubota, Y., Inagaki, S., Shimada, S., Kito, S., Eckenstein, F. and Tokyama, M., Neostriatal cholinergic neurons receive direct synaptic inputs from dopaminergic axons, Brain Res., 413 (1987) 179-184.
27. [28] Kuczenski, R. and Leith, N.J., Chronic amphetamine: is dopamine a link in or a mediator of the development of tolerance and reverse tolerance, Pharmacol. Biochem. Behav., 15 (1981) 405-413.
28. [29] Lehmann, J. and Langer, S.Z., The striatal cholinergic interneuron: synaptic target of dopaminergic terminals? Neuroscience, 10 (1983) 1105-1120.
29. [30] McGeer, P.L., Boulding, J.E., Gibson, W.C. and Foulkes, R.G., Drug-induced extrapyramidal reactions, J, Am. Med. Assoc., 177 (1961) 665-670.
30. [31] Nieoullon, A. and Kerkerian-Le Goff, L., Cellular interactions in the striatum involving neuronal systems using 'classical' neurotransmitters: possible functional implications, Mov. Disord., 7 (1992) 311-325.
31. [32] Paulson, P.A. and Robinson, T.E., Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats, Synapse, 19 (1995) 56-65.
32. [33] Phelps, P.E., Houser, C.R. and Vaughan, J.E., Immunocytochemical localization of choline acetyltransferase within the rat neostriatum: a correlated light and electron microscopic study of cholinergic neurons and synapses, J. Comp. Neurol., 238 (1985) 286-307.
33. [34] Pickel, V.M. and Chan, J., Spiny neurons lacking choline acetyl-transferase immunoreactivity are the major targets of cholinergic and catecholaminergic terminals in the rat striatum, J. Neurosci. Res., 25 (1990) 263-289.
34. [35] Robinson, T.E., Jurson, P.A., Bennett, J.A. and Bentgen, K.M., Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by past experience with ( + )-amphetamine: a microdialysis study in freely moving rats, Brain Res., 462 (1988) 211-222.
35. [36] Segal, D.S. and Kuczenski, R., Behavioral and neurochemical characteristics of stimulant-induced augmentation, Psychopharmacol. Bull., 23 (1987) 417-424.
36. [37] Segal, D.S., Geyer, M.A. and Schuckit, M.A., Stimulant-induced psychosis: an evaluation of animal models. In M.B.H. Youdim, W. Lovenberg, D.F. Sharman and J.R. Lagnado (Eds.), Essays in Neurochemistry and Neuropharmacology, Vol. 4, John Wiley and Sons, London, 1981, pp. 95-129.
37. [38] Stoof, J.C., Drukarch, B., DeBoer, P., Westerink, B.H.C. and Groenewegen, H.J., Regulation of the activity of striatal cholinergic neurons by dopamine, Neuroscience, 47 (1992) 755-770.